Dr Richard Saul Glick, DO | |
1444 Candlebrook Dr, Dresher, PA 19025-1023 | |
(215) 635-0333 | |
(215) 885-1721 |
Full Name | Dr Richard Saul Glick |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 1444 Candlebrook Dr, Dresher, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104989482 | NPI | - | NPPES |
0045371000 | Other | PA | HMO ID |
000090349 | Other | PA | HIGHMARK BLUE SHIELD ID |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207VG0400X | Obstetrics & Gynecology - Gynecology | OS002648L (Pennsylvania) | Secondary |
208D00000X | General Practice | OS002648L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Richard Saul Glick, DO 1444 Candlebrook Dr, Dresher, PA 19025-1023 Ph: (215) 635-0333 | Dr Richard Saul Glick, DO 1444 Candlebrook Dr, Dresher, PA 19025-1023 Ph: (215) 635-0333 |
News Archive
Are you active at your job? If you're like most workers, you probably aren't. And the consequences could be deadly.
Missouri is seeing a bigger decline in its Medicaid rolls than nearly any other state, a ranking that the Nixon administration attributes to an improving economy and critics blame on application snafus.
The American Gastroenterological Association Research Foundation has announced its 2011 research scholars. The grants have been awarded to four outstanding young gastroenterologists who promise to make significant strides in the field of gastrointestinal research.
UCB announced today that the U.S. Food and Drug Administration (FDA) approved Neupro (Rotigotine Transdermal System) for the treatment of the signs and symptoms of advanced stage idiopathic Parkinson's disease (PD) and as a treatment for moderate-to-severe primary Restless Legs Syndrome.
The Open Access journal PLoS Pathogens has published an article detailing research that identifies a new retrovirus in the tissue of human prostate tumors.
› Verified 2 days ago